MEDICATION GUIDE HUMIRA

Similar documents
o Your healthcare provider should test you for TB before starting CIMZIA.

Medication Guide Enbrel (en-brel) (etanercept)

Specialty Pharmacies: What they are. Why they are different.

MEDICATION GUIDE XELJANZ (ZEL JANS ) (tofacitinib)

MEDICATION GUIDE. (tocilizumab)

JUST FOR KIDS SELECTED IMPORTANT SAFETY INFORMATION

MEDICATION GUIDE HUMIRA (HU-MARE-AH) (adalimumab)

While every patient s experience is different, here are the general findings from clinical trials:

While every patient s experience is different, here are the general findings from clinical trials:

Show your doctor how juvenile idiopathic arthritis affects your child

ORENCIA (oh-ren-see-ah) (abatacept)

MEDICATION GUIDE SIMPONI (SIM-po-nee) (golimumab)

While every patient s experience is different, here are the general findings from clinical trials:

DEDICATED SUPPORT TO HELP YOU GET STARTED AND STAY ON TRACK THROUGHOUT YOUR TREATMENT

How does my new treatment work?

QUICK TIPS FOR USING THE SENSOREADY PEN

2013 FACT BOOK FACT BOOK

SIMPONI Golimumab (rmc) Consumer Medicine Information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

REMICADE Infliximab Consumer Medicine Information

Easy as knowing how to take the next step.

PATIENT INFORMATION. ORENCIA (oh-ren-see-ah) (abatacept) Lyophilized Powder for Intravenous Infusion

PART III: CONSUMER INFORMATION

The ORENCIA (abatacept) JIA Observational Registry

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

PART III: CONSUMER INFORMATION

Steps TO HELP YOU TALK WITH YOUR DOCTOR ABOUT YOUR TREATMENT OPTIONS

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PART III: PATIENT MEDICATION INFORMATION. ixekizumab

What prescribers need to know

MEDICATION GUIDE. BENLYSTA (ben-list-ah) (belimumab) Injection for intravenous use

Why have I been selected for treatment with adalimumab?

(continued) MEDICATION GUIDE Rx Only KEVZARA (KEV-za-ra) (sarilumab) injection, for subcutaneous use

KEEP UP THE FIGHT WITH. Little Victories

INSTRUCTIONS FOR USE ORENCIA (oh-ren-see-ah) (abatacept) Prefilled Syringe with BD UltraSafe Passive Needle Guard

Get an Insurance Benefits Review for ORENCIA (abatacept)

Golimumab (Simponi ) Therapy

HUMIRA VIAL. What is in this leaflet. What Humira is used for. Before you use Humira. Adalimumab (rch) Consumer Medicine Information

MEDICATION GUIDE PegIntron (peg-in-tron) (Peginterferon alfa-2b) for injection, for subcutaneous use

What are my treatment support resources?

Actemra concentrate for intravenous infusion

YOUR INTRODUCTION TO. INFLECTRA is a trademark of Hospira UK, a Pfizer company.

CIMZIA (certolizumab pegol)

ORENCIA (or-en-see-ah)

Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor

INFLECTRA is a trademark of Hospira UK, a Pfizer company.

Have a healthy discussion. Use this guide to start a. conversation. with your. healthcare provider

JANSSEN TO HIGHLIGHT DATA FROM BROAD RHEUMATOLOGY PORTFOLIO AT THE 2018 ANNUAL MEETING OF THE AMERICAN COLLEGE OF RHEUMATOLOGY

Humira Pre-filled Syringe Adalimumab (rch)

MEDICATION GUIDE. Epogen (Ee-po-jen) (epoetin alfa)

PATIENT INFORMATION. Auvi-Q (epinephrine injection) Auto-Injector For allergic emergencies (anaphylaxis)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. SYLVANT pronounced SILL-vant siltuximab for injection

MEDICATION GUIDE Rx Only KEVZARA (KEV-za-ra) (sarilumab) injection, for subcutaneous use What is the most important information I should know about

We will review the need for continuing treatment with you after 3 months and again after one year.

INSTRUCTIONS FOR USE HUMIRA 40 MG/0.8 ML, 20 MG/0.4 ML AND 10 MG/0.2 ML SINGLE-USE PREFILLED SYRINGE

Olumiant (baricitinib) tablets

ORENCIA (or-en-see-ah)

SAY HELLO TO CLEARER SKIN. SAY HELLO TO TREMFYA.

Anti-Tumor Necrosis Factor (Anti-TNF)

Contraindication: CinnoVex is contraindicated in patients with a history of hypersensitivity to interferon beta, or

RENFLEXIS. Treatment with RENFLEXIS. (infliximab-abda) Answers to questions you may have IMPORTANT SAFETY INFORMATION

Lymphoma, skin cancer, and other types of cancer have happened in people treated with this drug. Talk with your doctor.

Lymphoma, skin cancer, and other types of cancer have happened in people treated with this drug. Talk with your doctor.

GlaxoSmithKline Research Triangle Park, NC the ViiV Healthcare group of companies. All rights reserved. ZGN:XPI

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop.

1 P a g e. Systemic Juvenile Idiopathic Arthritis (SJIA) (1.3) Patients 2 years of age and older with active systemic juvenile idiopathic arthritis.

contains the active ingredient tocilizumab (rch) It does not contain all the available information.

Humira Pen Adalimumab (rch)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

Package leaflet: Information for the patient

Package Leaflet: Information for the user. Simponi 50 mg solution for injection in pre-filled syringe golimumab

Medication Guide. VIDEX EC (VY-dex Ee-see) (didanosine, also known as ddi) Delayed-Release Capsules Enteric-Coated Beadlets

What You Need to Know About ARZERRA (ofatumumab)

acting aggressive, being angry or violent yourself, or feeling hopeless)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

MEDICATION GUIDE. Peganone 250 mg Tablets (PEG-ah-noan) (ethotoin tablets, USP)

Patient Information Entecavir Tablets (en-tek-ah-veer)

Some general information on hepatitis A infection is given at the end of this leaflet.

FOR ADULTS WITH ACTIVE PSORIATIC ARTHRITIS

FDA APPROVED MEDICATION GUIDE

Tuscarawas County Health Department. Vivitrol Treatment Consent

For males: use effective birth control during your treatment with INLYTA. Talk to your doctor about birth control methods.

MEDICATION GUIDE. (belatacept) For Injection, For Intravenous Use

Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension

Humira Pen. What is in this leaflet. What Humira is used for. Adalimumab (rch) Consumer Medicine Information

Before you use Enbrel. When you must not use it

Your treatment with XELJANZ

What is the most important information I should know about bortezomib? What should I discuss with my healthcare provider before receiving bortezomib?

All medicines have risks and benefits. Your doctor has weighed the risks of you being given Mabthera SC against the benefits expected for you.

Infliximab (Remicade ) Therapy

AMGEVITA (adalimumab)

Influvac Inactivated influenza vaccine [surface antigen]

PATIENT SAFETY BROCHURE; IMPORTANT SAFETY INFORMATION FOR PATIENTS. Before starting on Soliris Important safety information for patients

For the Patient: USMAVFIPI

belimumab (rmc) 120 mg and 400 mg powder Please read this leaflet carefully before you are given BENLYSTA.

Glatopa is prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis (MS).

PRESCRIBER SAFETY BROCHURE; IMPORTANT SAFETY INFORMATION FOR THE HEALTHCARE PROVIDER

Humira (adalimumab) DRUG.00002

Package Leaflet: Information for the user. Simponi 100 mg solution for injection in pre-filled pen golimumab

Transcription:

MEDICATION GUIDE HUMIRA (Hu-MARE-ah) (adalimumab) injection Read the Medication Guide that comes with HUMIRA before you start taking it and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking with your doctor about your medical condition or treatment. What is the most important information I should know about HUMIRA? HUMIRA is a medicine that affects your immune system. HUMIRA can lower the ability of your immune system to fight infections. Serious infections have happened in people taking HUMIRA. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi or bacteria that have spread throughout the body. Some people have died from these infections. Your doctor should test you for TB before starting HUMIRA. Your doctor should check you closely for signs and symptoms of TB during treatment with HUMIRA. You should not start taking HUMIRA if you have any kind of infection unless your doctor says it is okay. Before starting HUMIRA, tell your doctor if you: think you have an infection or have symptoms of infection such as: fever, sweats, or chills muscle aches cough shortness of breath blood in phlegm warm, red, or painful skin or sores on your body diarrhea or stomach pain burning when you urinate or urinate more often than normal feel very tired weight loss are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes have TB, or have been in close contact with someone with TB were born in, lived in, or traveled to countries where there is more risk for getting TB. Ask your doctor if you are not sure. live or have lived in certain parts of the country (such as the Ohio and Mississippi River valleys) where there is an increased risk for getting certain kinds of fungal infections (histoplasmosis, coccidioidomycosis, or blastomycosis). These infections may happen or become more severe if you use HUMIRA. Ask your doctor if you do not know if you have lived in an area where these infections are common. have or have had hepatitis B use the medicine ORENCIA (abatacept), KINERET (anakinra), RITUXAN (rituximab), IMURAN (azathioprine), or PURINETHOL (6 mercaptopurine, 6-MP). are scheduled to have major surgery After starting HUMIRA, call your doctor right away if you have an infection, or any sign of an infection. HUMIRA can make you more likely to get infections or make any infection that you may have worse. Cancer

For children and adults taking TNF-blockers, including HUMIRA, the chances of getting cancer may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF-blockers. People with RA, especially more serious RA, may have a higher chance for getting a kind of cancer called lymphoma. If you use TNF blockers including HUMIRA your chance of getting two types of skin cancer may increase (basal cell cancer and squamous cell cancer of the skin). These types of cancer are generally not life-threatening if treated. Tell your doctor if you have a bump or open sore that doesn t heal. Some people receiving TNF blockers including HUMIRA developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. Most of these people were male teenagers or young men. Also, most people were being treated for Crohn s disease or ulcerative colitis with another medicine called IMURAN (azathioprine) or PURINETHOL (6-mercaptopurine, 6 MP). What is HUMIRA? HUMIRA is a medicine called a Tumor Necrosis Factor (TNF) blocker. HUMIRA is used: To reduce the signs and symptoms of: moderate to severe rheumatoid arthritis (RA) in adults. HUMIRA can be used alone, with methotrexate, or with certain other medicines. moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children 2 years and older. HUMIRA can be used alone, with methotrexate, or with certain other medicines. psoriatic arthritis (PsA) in adults. HUMIRA can be used alone or with certain other medicines. ankylosing spondylitis (AS) in adults. moderate to severe Crohn s disease (CD) in adults when other treatments have not worked well enough. moderate to severe Crohn s disease (CD) in children 6 years and older when other treatments have not worked well enough. moderate to severe hidradenitis suppurativa (HS) in adults. In adults, to help get moderate to severe ulcerative colitis (UC) under control (induce remission) and keep it under control (sustain remission) when certain other medicines have not worked well enough. It is not known if HUMIRA is effective in people who stopped responding to or could not tolerate TNF-blocker medicines. To treat moderate to severe chronic (lasting a long time) plaque psoriasis (Ps) in adults who have the condition in many areas of their body and who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills). To treat non-infectious intermediate, posterior and panuveitis (UV) in adults. What should I tell my doctor before taking HUMIRA? HUMIRA may not be right for you. Before starting HUMIRA, tell your doctor about all of your health conditions, including if you: have an infection. See What is the most important information I should know about HUMIRA? have or have had cancer. have any numbness or tingling or have a disease that affects your nervous system such as multiple sclerosis or Guillain-Barré syndrome. have or had heart failure.

have recently received or are scheduled to receive a vaccine. You may receive vaccines, except for live vaccines while using HUMIRA. Children should be brought up to date with all vaccines before starting HUMIRA. are allergic to rubber or latex. Tell your doctor if you have any allergies to rubber or latex. The needle cover for the HUMIRA Pen 40 mg/0.8 ml, HUMIRA 40 mg/0.8 ml prefilled syringe, HUMIRA 20 mg/0.4 ml prefilled syringe, and HUMIRA 10 mg/0.2 ml prefilled syringe may contain natural rubber or latex. The black needle cover for the HUMIRA Pen 80 mg/0.8 ml, HUMIRA 80 mg/0.8 ml prefilled syringe, HUMIRA Pen 40 mg/0.4 ml, HUMIRA 40 mg/0.4 ml prefilled syringe, HUMIRA 20 mg/0.2 ml prefilled syringe, HUMIRA 10 mg/0.1 ml prefilled syringe and the vial stopper on the HUMIRA institutional use vial are not made with natural rubber or latex. are allergic to HUMIRA or to any of its ingredients. See the end of this Medication Guide for a list of ingredients in HUMIRA. are pregnant or plan to become pregnant. It is not known if HUMIRA will harm your unborn baby. HUMIRA should only be used during a pregnancy if needed. have a baby and you were using HUMIRA during your pregnancy. Tell your baby s doctor before your baby receives any vaccines. breastfeeding or plan to breastfeed. You and your doctor should decide if you will breastfeed or use HUMIRA. You should not do both. Tell your doctor about all the medicines you take, including prescription and over-thecounter medicines, vitamins, and herbal supplements. Especially tell your doctor if you use: ORENCIA (abatacept), KINERET (anakinra), REMICADE (infliximab), ENBREL (etanercept), CIMZIA (certolizumab pegol) or SIMPONI (golimumab), because you should not use HUMIRA while you are also using one of these medicines. RITUXAN (rituximab). Your doctor may not want to give you HUMIRA if you have received RITUXAN (rituximab) recently. IMURAN (azathioprine) or PURINETHOL (6 mercaptopurine, 6-MP). Keep a list of your medicines with you to show your doctor and pharmacist each time you get a new medicine. How should I take HUMIRA? HUMIRA is given by an injection under the skin. Your doctor will tell you how often to take an injection of HUMIRA. This is based on your condition to be treated. Do not inject HUMIRA more often than you were prescribed. See the Instructions for Use inside the carton for complete instructions for the right way to prepare and inject HUMIRA. Make sure you have been shown how to inject HUMIRA before you do it yourself. You can call your doctor or 1-800-4HUMIRA (1-800-448-6472) if you have any questions about giving yourself an injection. Someone you know can also help you with your injection after they have been shown how to prepare and inject HUMIRA. Do not try to inject HUMIRA yourself until you have been shown the right way to give the injections. If your doctor decides that you or a caregiver may be able to give your injections of HUMIRA at home, you should receive training on the right way to prepare and inject HUMIRA. Do not miss any doses of HUMIRA unless your doctor says it is okay. If you forget to take HUMIRA, inject a dose as soon as you remember. Then, take your next dose at your regular scheduled time. This will put you back on schedule. In case you are not sure when to inject HUMIRA, call your doctor or pharmacist.

If you take more HUMIRA than you were told to take, call your doctor. What are the possible side effects of HUMIRA? HUMIRA can cause serious side effects, including: See What is the most important information I should know about HUMIRA? Serious Infections. Your doctor will examine you for TB and perform a test to see if you have TB. If your doctor feels that you are at risk for TB, you may be treated with medicine for TB before you begin treatment with HUMIRA and during treatment with HUMIRA. Even if your TB test is negative your doctor should carefully monitor you for TB infections while you are taking HUMIRA. People who had a negative TB skin test before receiving HUMIRA have developed active TB. Tell your doctor if you have any of the following symptoms while taking or after taking HUMIRA: cough that does not go away low grade fever weight loss loss of body fat and muscle (wasting) Hepatitis B infection in people who carry the virus in their blood. If you are a carrier of the hepatitis B virus (a virus that affects the liver), the virus can become active while you use HUMIRA. Your doctor should do blood tests before you start treatment, while you are using HUMIRA, and for several months after you stop treatment with HUMIRA. Tell your doctor if you have any of the following symptoms of a possible hepatitis B infection: muscle aches feel very tired dark urine skin or eyes look yellow little or no appetite vomiting clay-colored bowel movements fever chills stomach discomfort skin rash Allergic reactions. Allergic reactions can happen in people who use HUMIRA. Call your doctor or get medical help right away if you have any of these symptoms of a serious allergic reaction: hives trouble breathing swelling of your face, eyes, lips or mouth Nervous system problems. Signs and symptoms of a nervous system problem include: numbness or tingling, problems with your vision, weakness in your arms or legs, and dizziness. Blood problems. Your body may not make enough of the blood cells that help fight infections or help to stop bleeding. Symptoms include a fever that does not go away, bruising or bleeding very easily, or looking very pale. New heart failure or worsening of heart failure you already have. Call your doctor right away if you get new worsening symptoms of heart failure while taking HUMIRA, including: shortness of breath swelling of your ankles or feet sudden weight gain Immune reactions including a lupus-like syndrome. Symptoms include chest discomfort or pain that does not go away, shortness of breath, joint pain, or a rash on your cheeks or arms that gets worse in the sun. Symptoms may improve when you stop HUMIRA. Liver Problems. Liver problems can happen in people who use TNF-blocker medicines. These problems can lead to liver failure and death. Call your doctor right away if you have

any of these symptoms: feel very tired poor appetite or vomiting skin or eyes look yellow pain on the right side of your stomach (abdomen) Psoriasis. Some people using HUMIRA had new psoriasis or worsening of psoriasis they already had. Tell your doctor if you develop red scaly patches or raised bumps that are filled with pus. Your doctor may decide to stop your treatment with HUMIRA. Call your doctor or get medical care right away if you develop any of the above symptoms. Your treatment with HUMIRA may be stopped. Common side effects with HUMIRA include: injection site reactions: redness, rash, swelling, itching, or bruising. These symptoms usually will go away within a few days. Call your doctor right away if you have pain, redness or swelling around the injection site that does not go away within a few days or gets worse. upper respiratory infections (including sinus infections) headaches rash These are not all the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away. Ask your doctor or pharmacist for more information. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. How should I store HUMIRA? Store HUMIRA in the refrigerator at 36ºF to 46ºF (2ºC to 8ºC). Store HUMIRA in the original carton until use to protect it from light. Do not freeze HUMIRA. Do not use HUMIRA if frozen, even if it has been thawed. Refrigerated HUMIRA may be used until the expiration date printed on the HUMIRA carton, dose tray, Pen or prefilled syringe. Do not use HUMIRA after the expiration date. If needed, for example when you are traveling, you may also store HUMIRA at room temperature up to 77 F (25 C) for up to 14 days. Store HUMIRA in the original carton until use to protect it from light. Throw away HUMIRA if it has been kept at room temperature and not been used within 14 days. Record the date you first remove HUMIRA from the refrigerator in the spaces provided on the carton and dose tray. Do not store HUMIRA in extreme heat or cold. Do not use a Pen or prefilled syringe if the liquid is cloudy, discolored, or has flakes or particles in it. Do not drop or crush HUMIRA. The prefilled syringe is glass. Keep HUMIRA, injection supplies, and all other medicines out of the reach of children. General information about the safe and effective use of HUMIRA Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use HUMIRA for a condition for which it was not prescribed. Do not give HUMIRA to other people, even if they have the same condition. It may harm them. This Medication Guide summarizes the most important information about HUMIRA. If you would like more information, talk with your doctor. You can ask your doctor or pharmacist for information about HUMIRA that is written for health professionals. For more information go to www.humira.com or you can enroll in a patient support program by calling 1-800-4HUMIRA (1-800-448-6472).

What are the ingredients in HUMIRA? Active ingredient: adalimumab HUMIRA Pen 40 mg/0.8 ml, HUMIRA 40 mg/0.8 ml prefilled syringe, HUMIRA 20 mg/0.4 ml prefilled syringe, HUMIRA 10 mg/0.2 ml prefilled syringe, and HUMIRA 40 mg/0.8 ml institutional use vial: Inactive ingredients: citric acid monohydrate, dibasic sodium phosphate dihydrate, mannitol, monobasic sodium phosphate dihydrate, polysorbate 80, sodium chloride, sodium citrate and Water for Injection. Sodium hydroxide is added as necessary to adjust ph. HUMIRA Pen 80 mg/0.8 ml, HUMIRA 80 mg/0.8 ml prefilled syringe, HUMIRA Pen 40 mg/0.4 ml, HUMIRA 40 mg/0.4 ml prefilled syringe, HUMIRA 20 mg/0.2 ml prefilled syringe and HUMIRA 10 mg/0.1 ml prefilled syringe: Inactive ingredients: mannitol, polysorbate 80, and Water for Injection. Manufactured by: AbbVie Inc., North Chicago, IL 60064, U.S.A. US License Number 1889 This Medication Guide has been approved by the U.S. Food and Drug Administration. 03-B590/20018628 Revised: 10/2017